U.S. Markets close in 5 hrs 41 mins
  • S&P 500

    3,373.22
    +10.22 (+0.30%)
     
  • Dow 30

    27,828.59
    +46.89 (+0.17%)
     
  • Nasdaq

    11,261.32
    +93.81 (+0.84%)
     
  • Russell 2000

    1,515.35
    +7.66 (+0.51%)
     
  • Crude Oil

    38.37
    -1.85 (-4.60%)
     
  • Gold

    1,904.00
    +8.50 (+0.45%)
     
  • Silver

    23.58
    +0.09 (+0.37%)
     
  • EUR/USD

    1.1748
    +0.0022 (+0.1880%)
     
  • 10-Yr Bond

    0.7020
    +0.0250 (+3.69%)
     
  • Vix

    26.19
    -0.18 (-0.68%)
     
  • GBP/USD

    1.2875
    -0.0046 (-0.3579%)
     
  • USD/JPY

    105.6390
    +0.2090 (+0.1982%)
     
  • BTC-USD

    10,866.85
    +70.82 (+0.66%)
     
  • CMC Crypto 200

    234.01
    +10.31 (+4.61%)
     
  • FTSE 100

    5,858.42
    -7.68 (-0.13%)
     
  • Nikkei 225

    23,185.12
    0.00 (0.00%)
     

Rite Aid Expands COVID-19 Testing to 258 Total Locations

161 Additional Self-Swab Testing Sites Include Expansion to West Coast

Rite Aid (NYSE: RAD) will continue to expand its COVID-19 testing capacity with the addition of 161 drive-through testing locations opening on July 16 in partnership with the U.S. Department of Health and Human Services (HHS).

Rite Aid’s COVID-19 testing sites will now span coast-to-coast, with the addition of locations in California, Oregon and Washington, and an increased number of locations in Idaho, Maryland, Massachusetts, Michigan, New Hampshire, New Jersey, New York, Ohio, Pennsylvania and Virginia.

Similar to Rite Aid’s existing drive-through locations, the new sites will utilize self-swab nasal tests overseen by Rite Aid pharmacists, and will operate Monday through Friday 10 a.m. - 8 p.m. and Saturday and Sunday 10 a.m. - 5 p.m.

Rite Aid’s COVID-19 nasal tests are available for all adults, regardless if they are experiencing virus symptoms, in accordance with the Centers for Disease Control and Prevention (CDC) guidance. At all testing locations, patients are required to provide government issued identification, be at least 18 years old and need to pre-register online at www.riteaid.com in order to schedule a time slot for testing.

Now operating 258 total testing sites, Rite Aid will more than double its testing capabilities, with the capacity to conduct 94,000 tests weekly across all locations. A complete list of Rite Aid's COVID-19 testing sites can be found at www.riteaid.com.

Rite Aid partners with Verily and its Baseline COVID-19 Testing Program to provide screening, scheduling and return of results to participants for Rite Aid testing sites. BioReference Laboratories provides COVID-19 laboratory testing.

Clinical oversight for the COVID-19 testing program is provided by PWNHealth, a national clinician network that enables safe and easy access to diagnostic testing.

Rite Aid will continue to provide regular updates on the company's progress with COVID-19 testing.

About Rite Aid Corporation

Rite Aid Corporation is on the front lines of delivering healthcare services and retail products to more than 1.6 million Americans daily. Our pharmacists are uniquely positioned to engage with customers and improve their health outcomes. We provide an array of whole being health products and services for the entire family through over 2,400 retail pharmacy locations across 18 states. Through EnvisionRxOptions, we provide pharmacy benefits and services to approximately 4 million members nationwide. For more information, www.riteaid.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200715005504/en/

Contacts

MEDIA:
Chris Savarese
717-975-5718
christopher.savarese@riteaid.com